Bill Sponsor
House Bill 4810
116th Congress(2019-2020)
Opioid Prescription Verification Act of 2019
Introduced
Introduced
Introduced in House on Oct 23, 2019
Overview
Text
Introduced in House 
Oct 23, 2019
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Oct 23, 2019)
Oct 23, 2019
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 4810 (Introduced-in-House)


116th CONGRESS
1st Session
H. R. 4810


To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

October 23, 2019

Mr. Rodney Davis of Illinois (for himself, Mr. Van Drew, Mr. Bucshon, Mr. Shimkus, and Mr. Latta) introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To facilitate responsible, informed dispensing of controlled substances and other prescribed medications, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Opioid Prescription Verification Act of 2019”.

SEC. 2. Materials for training pharmacists on certain circumstances under which a pharmacist may decline to fill a prescription.

(a) Updates to materials.—Section 3212(a) of the SUPPORT for Patients and Communities Act (Public Law 115–271) is amended by striking “Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate” and inserting “The Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, Commissioner of Food and Drugs, Director of the Centers for Disease Control and Prevention, and Assistant Secretary for Mental Health and Substance Use, shall develop and disseminate not later than 1 year after the date of enactment of this Act, and update periodically thereafter”.

(b) Materials included.—Section 3212(b) of the SUPPORT for Patients and Communities Act (Public Law 115–271) is amended—

(1) by redesignating paragraphs (1) and (2) as paragraphs (2) and (3), respectively; and

(2) by inserting before paragraph (2), as so redesignated, the following new paragraph:

“(1) pharmacists on how to verify the identity of individuals picking up prescriptions;”.

(c) Materials for training on verification of identity.—Section 3212 of the SUPPORT for Patients and Communities Act (Public Law 115–271) is amended by adding at the end the following new subsection:

“(d) Materials for training on verification of identity of individuals picking up prescribed medications.—Not later than 6 months after the date of enactment of this subsection, the Secretary of Health and Human Services, after seeking stakeholder input in accordance with subsection (c), shall—

“(1) update the materials developed under subsection (a) to include information for pharmacists on how to verify the identity of individuals picking up prescribed medications; and

“(2) disseminate, as appropriate, the updated materials.”.

SEC. 3. Incentivizing States To facilitate responsible, informed dispensing of controlled substances.

(a) In general.—Section 392A of the Public Health Service Act (42 U.S.C. 280b–1) is amended—

(1) by redesignating subsections (c) and (d) as subsections (d) and (e), respectively; and

(2) by inserting after subsection (b) the following new subsection:

“(c) Preference.—In determining the amounts of grants awarded to States under subsections (a) and (b), the Director of the Centers for Disease Control and Prevention may give preference to States in accordance with such criteria as the Director may specify and may choose to give preference to States that—

“(1) maintain a prescription drug monitoring program;

“(2) require dispensers of controlled substances in schedule II, III, or IV to verify the identity of the person who picks up a prescribed medication by requiring such person to present a photo identification card that is valid as determined by the respective State; and

“(3) require dispensers of such controlled substances to enter certain information about the purchase of such controlled substances into the respective State’s prescription drug monitoring program, including—

“(A) the National Drug Code or, in the case of compounded medications, compound identifier;

“(B) the quantity dispensed;

“(C) the name of the patient;

“(D) the name of the ultimate user;

“(E) the name of the person who picks up the controlled substance, if different from the patient and ultimate user; and

“(F) the date filled.”.

(b) Definitions.—Subsection (d) of section 392A of the Public Health Service Act (42 U.S.C. 280b–1), as redesignated by subsection (a)(1), is amended to read as follows:

“(d) Definitions.—In this section:

“(1) CONTROLLED SUBSTANCE.—The term ‘controlled substance’ has the meaning given that term in section 102 of the Controlled Substances.

“(2) DISPENSER.—The term ‘dispenser’ means a physician, pharmacist, or other person that dispenses a controlled substance to an ultimate user.

“(3) INDIAN TRIBE.—The term ‘Indian tribe’ has the meaning given that term in section 4 of the Indian Self-Determination and Education Assistance Act.

“(4) STATE.—The term ‘State’ means each of the 50 States, the District of Columbia, and any commonwealth or territory of the United States.

“(5) ULTIMATE USER.—The term ‘ultimate user’ means a person who has obtained from a dispenser, and who possesses, a controlled substance for the person’s own use, for the use of a member of the person’s household, or for the use of an animal.”.